Ching-Yuan Kuo

Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Hagop M. Kantarjian, Xavier Thomas, Anna Dmoszyńska et al. · Journal of Clinical Oncology · 2012 · 1.2K citations · Full text

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

Alemnew F. Dagnew, Osman İlhan, Won Sik Lee et al. · The Lancet Infectious Diseases · 2019 · 242 citations

Vaccination, Vaccine Safety, Vaccinology +11

A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients

Hui‐Jen Tsai, Shih Sheng Jiang, Wen-Chun Hung et al. · Scientific Reports · 2017 · 70 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Phase Ii Study +19

The Relationship between Brown Adipose Tissue Activity and Neoplastic Status: an 18F-FDG PET/CT Study in the Tropics

Yung‐Cheng Huang, Tai‐Been Chen, Chien-Chin Hsu et al. · Lipids in Health and Disease · 2011 · 38 citations · Full text

Results from a randomized phase III trial of decitabine versus supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed AML.

Xavier Thomas, Anna Dmoszyńska, Agnieszka Wierzbowska et al. · Journal of Clinical Oncology · 2011 · 29 citations

Pharmacotherapy, Myeloid Neoplasia, Hematological Malignancy +16